MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Peri-operative dopaminergic replacement protocol with rotigotine in Parkinson’s disease patients

L. Abraira del Fresno, L. Ispierto, A.M. Crespo, T. Canento, D. Vilas, M. Gonzalez, F. Sala, L. Morató, J. Sánchez-Ojanguren, R. Álvarez (Barcelona, Spain)

Meeting: 2016 International Congress

Abstract Number: 1939

Keywords: Dopamine agonists

Session Information

Date: Thursday, June 23, 2016

Session Title: Parkinson's disease: Clinical trials, pharmacology and treatment

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate the accomplishment of a peri-operative dopaminergic replacement protocol established in our centre from 2011 to 2014, and analyse the main factors associated with a worse compliance.

Background: Parkinson’s disease (PD) patients have a higher admission rate than general population. Complications related to dopaminergic treatment withdrawal are not uncommon, especially in PD patients hospitalized for surgical procedures. A protocol for dopaminergic replacement with rotigotine transdermal patch was established in collaboration with anaesthesiology department in 2011 in our centre.

Methods: We assessed 169 admissions for surgical procedures of PD patients between 2011 and 2014 and 49 admissions previous to the protocol instauration (2009 -2010). We classified these patients whether rotigotine was administered or not and we analysed clinical parameters, average hospital stay, rest days, prescription of non-recommended drugs (mainly antiemetics and neuroleptics), protocol fulfilment and emergency or scheduled admissions.

Results: Between 2009 and 2010 (pre-protocol) rotigotine was administered in 6,1% of patients compared to 75,9% in 2011 (post-protocol). The protocol accomplishment was of 83.8% in Neurosurgery department, 63% in Traumatology and 51.7% in General surgery. A lower average hospital stay (7 [5-11], 8 [5-13]; p=0.067), less rest days (1 [1-3] vs. 1 [2-4]; p=0.04) and lower prescription of non-recommended drugs (56,4% vs 36,5%; p=0,039) were observed in patients in whom rotigotine protocol was carried out. There was a worse compliance of the protocol (56.3% vs. 74.3%; p=0.007) and a higher prescription of non-recommended drugs (69,6% vs 32,7%; p<0,001) for emergency admissions than for scheduled ones.

Conclusions: The establishment of a peri-operative dopaminergic replacement protocol with rotigotine in Parkinson’s disease patients has allowed a significant increase in its administration, contributing to a lower average hospital stay and prescription of non-recommended drugs. More strategies are needed to increase the protocol accomplishment and to reduce the prescription of non-recommended drugs in emergency admissions and in some surgery departments.

To cite this abstract in AMA style:

L. Abraira del Fresno, L. Ispierto, A.M. Crespo, T. Canento, D. Vilas, M. Gonzalez, F. Sala, L. Morató, J. Sánchez-Ojanguren, R. Álvarez. Peri-operative dopaminergic replacement protocol with rotigotine in Parkinson’s disease patients [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/peri-operative-dopaminergic-replacement-protocol-with-rotigotine-in-parkinsons-disease-patients/. Accessed May 17, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/peri-operative-dopaminergic-replacement-protocol-with-rotigotine-in-parkinsons-disease-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley